RPG Investment Advisory LLC raised its holdings in shares of Aurora Cannabis Inc (NYSE:ACB) by 195.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,475 shares of the company’s stock after purchasing an additional 3,625 shares during the quarter. RPG Investment Advisory LLC’s holdings in Aurora Cannabis were worth $50,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. ETF Managers Group LLC bought a new position in shares of Aurora Cannabis in the fourth quarter worth approximately $40,454,000. Norges Bank purchased a new stake in shares of Aurora Cannabis during the fourth quarter valued at approximately $30,915,000. TD Asset Management Inc. purchased a new stake in shares of Aurora Cannabis during the fourth quarter valued at approximately $16,657,000. JW Asset Management LLC purchased a new stake in Aurora Cannabis in the fourth quarter worth $10,734,000. Finally, D. E. Shaw & Co. Inc. purchased a new stake in Aurora Cannabis in the fourth quarter worth $10,504,000. 9.04% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts have commented on the company. ValuEngine raised Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Tuesday, March 19th. TheStreet upgraded Aurora Cannabis from a “d+” rating to a “c” rating in a report on Thursday, April 4th. GMP Securities upgraded Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Wednesday, March 13th. Bank of America assumed coverage on Aurora Cannabis in a report on Wednesday, April 17th. They set a “buy” rating and a $11.00 price target for the company. Finally, Jefferies Financial Group started coverage on Aurora Cannabis in a report on Monday, February 25th. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $9.86.
Aurora Cannabis (NYSE:ACB) last released its quarterly earnings data on Monday, February 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.02. Aurora Cannabis had a positive return on equity of 3.95% and a negative net margin of 57.54%. The business had revenue of $41.00 million for the quarter. As a group, equities analysts forecast that Aurora Cannabis Inc will post -0.18 earnings per share for the current fiscal year.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
See Also: Mutual Funds
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.